A-21

SOLUTION · ALTERNARIA ALTERNATA 30 [hp_X]/mL, ASPERGILLUS NIGER VAR. NIGER 30 [hp_X]/mL, COCHLIOBOLUS SPICIFER 30 [hp_X]/mL, GIBBERELLA FUJIKUROI 30 [hp_X]/mL, COCHLIOBOLUS SATIVUS 30 [hp_X]/mL, CLADOSPORIUM BRUHNEI 30 [hp_X]/mL, MUCOR PLUMBEUS 30 [hp_X]/mL, PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM 30 [hp_X]/mL, AUREOBASIDIUM PULLULANS VAR. PULLUTANS 30 [hp_X]/mL, RHIZOPUS STOLONIFER 30 [hp_X]/mL

United StatesActive

Marketing holder: DNA Labs, Inc.

Verified 2026-10-09 · openFDA NDC

Source: openFDA NDC

Composition

ALTERNARIA ALTERNATA · 30 [hp_X]/mL
ASPERGILLUS NIGER VAR. NIGER · 30 [hp_X]/mL
COCHLIOBOLUS SPICIFER · 30 [hp_X]/mL
GIBBERELLA FUJIKUROI · 30 [hp_X]/mL
COCHLIOBOLUS SATIVUS · 30 [hp_X]/mL
CLADOSPORIUM BRUHNEI · 30 [hp_X]/mL
MUCOR PLUMBEUS · 30 [hp_X]/mL
PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM · 30 [hp_X]/mL
AUREOBASIDIUM PULLULANS VAR. PULLUTANS · 30 [hp_X]/mL
RHIZOPUS STOLONIFER · 30 [hp_X]/mL

Registration

Registration number: 58264-0313
Registration status: Active
Dispensing: Over the counter
Route: SUBLINGUAL

Sources

product · openFDA NDC · 58264-0313 · Verified 2026-10-09 · open in source
registration_status · openFDA NDC · 58264-0313 · Verified 2026-10-09 · open in source
ingredients.0 · openFDA NDC · 58264-0313 · Verified 2026-10-09 · open in source
ingredients.1 · openFDA NDC · 58264-0313 · Verified 2026-10-09 · open in source
ingredients.2 · openFDA NDC · 58264-0313 · Verified 2026-10-09 · open in source
ingredients.3 · openFDA NDC · 58264-0313 · Verified 2026-10-09 · open in source
ingredients.4 · openFDA NDC · 58264-0313 · Verified 2026-10-09 · open in source
ingredients.5 · openFDA NDC · 58264-0313 · Verified 2026-10-09 · open in source
ingredients.6 · openFDA NDC · 58264-0313 · Verified 2026-10-09 · open in source
ingredients.7 · openFDA NDC · 58264-0313 · Verified 2026-10-09 · open in source
ingredients.8 · openFDA NDC · 58264-0313 · Verified 2026-10-09 · open in source
ingredients.9 · openFDA NDC · 58264-0313 · Verified 2026-10-09 · open in source